Skip to main content
Caplight Logo









Renephra Ltd

Renephra Ltd

Private
ManchesterHealthcare & Life Scienceshttps://renephra.com

Last Round

Grant

Jul 30, 2019

Total Funding Raised

$171,000

Company Overview

Renephra Ltd is a medical device company that develops transdermal fluid removal technology for the treatment of chronic oedema and fluid overload.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

transdermal fluid removalTFRmicroneedle patchwearable medical devicechronic oedemafluid overloadminimally invasivehome-based carediuretic alternativemedtechheart failure treatmentdisposable medical deviceremote patient monitoringdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renephra Ltd Comparables

Compare Renephra Ltd with similar companies based on industry and business-model similarity.

Renephra Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AquaPass Medical Ltd.
78%
Lymphatica Medtech SA
63%
PrīmSphera
61%

Renephra Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 30, 2019
SeedDec 17, 2018
GrantDec 12, 2017
SeedApr 1, 2016

Renephra Ltd Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2019

    $75K grant received from Innovate UK.

  • Dec 17, 2018

    Raised Seed round with Catapult Ventures, gmclifesciencesfund, and others.

Renephra Ltd Filings

Explore SEC and related filing metadata, where available.

Renephra Ltd filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Renephra Ltd's valuation, stock price, and market status.

Is Renephra Ltd a public or private company?

Renephra Ltd is a private company.

What is the current stock price of Renephra Ltd?

Renephra Ltd is a private company with no public stock price. Caplight tracks Renephra Ltd's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Renephra Ltd worth (valuation)?

Valuation information for Renephra Ltd is not publicly available.

Can I buy Renephra Ltd stock?

Renephra Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Renephra Ltd's last funding round?

Renephra Ltd's most recent funding round was Grant on July 30, 2019.

Who are the main investors in Renephra Ltd?

Key investors in Renephra Ltd include Innovate UK, Deepbridge Capital, NorthInvest, SPARK Impact, Catapult Ventures.

Will Renephra Ltd IPO soon?

No public IPO plans have been announced for Renephra Ltd.

How can I track Renephra Ltd secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Renephra Ltd's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersManchester
Employee Range1
Year Founded2009
Last FundingJul 30, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?